Predicted early fusion intermediates in the spike of ACE2-utilising bat coronavirus unveil broad-spectrum antiviral mechanisms

Lujia Sun; Zhimin Liu; Lixiao Xing; Xiaoxing Liang; Lu Lu; Shibo Jiang; Lei Sun; Xinling Wang

doi:10.1002/ctm2.70459

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (9) : e70459 DOI: 10.1002/ctm2.70459

INVITED LETTER

Predicted early fusion intermediates in the spike of ACE2-utilising bat coronavirus unveil broad-spectrum antiviral mechanisms

Author information +

History +

PDF

Cite this article

Download citation ▾

Lujia Sun, Zhimin Liu, Lixiao Xing, Xiaoxing Liang, Lu Lu, Shibo Jiang, Lei Sun, Xinling Wang. Predicted early fusion intermediates in the spike of ACE2-utilising bat coronavirus unveil broad-spectrum antiviral mechanisms. Clinical and Translational Medicine, 2025, 15(9): e70459 DOI:10.1002/ctm2.70459

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Xing L, Liu Z, Wang X, et al. Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target. Cell. 2025; 188(5): 1297-1314. e1224.

[2]	Jiang S, Wu F. Global surveillance and countermeasures for ACE2-using MERS-related coronaviruses with spillover risk. Cell. 2025; 188(6): 1465-1468.

[3]	Zhu G, Zhu C, Zhu Y, Sun F. Minireview of progress in the structural study of SARS-CoV-2 proteins. Curr Res Microb Sci. 2020; 1: 53-61.

[4]	Xiong Q, Cao L, Ma C, et al. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors. Nature. 2022; 612(7941): 748-757.

[5]	Ma CB, Liu C, Park YJ, et al. Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses. Cell. 2025; 188(6): 1693-1710. e1618.

[6]	Park YJ, Liu C, Lee J, et al. Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses. Cell. 2025; 188(6): 1711-1728. e1721.

[7]	Chen J, Zhang W, Li Y, et al. Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor. Cell. 2025; 188(6): 1729-1742. e1716.

[8]	Waterhouse A, Bertoni M, Bienert S, et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 2018; 46(W1): W296-W303.

[9]	Shi W, Cai Y, Zhu H, et al. Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane. Nature. 2023; 619(7969): 403-409.

[10]	Xia S, Lan Q, Zhu Y, et al. Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation. Signal Transduct Target Ther. 2021; 6(1): 288.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.